<DOC>
	<DOCNO>NCT00862394</DOCNO>
	<brief_summary>To demonstrate CHF 1535 via NEXT DPI ( beclomethasone dipropionate + formoterol fumarate 100 + 6 μg ) , 1 inhalation 2 inhalation twice daily , 12 week non-inferior correspond dose CHF 1535 via HFA-134a `` extrafine '' pMDI term pulmonary function moderate severe symptomatic asthmatic patient age ≥ 12 year treatment inhale corticosteroid</brief_summary>
	<brief_title>A Study Comparing Efficacy Safety CHF 1535 ( BDP +FF ) Inhalation Powder , Administered Via NEXT Inhaler , Versus CHF 1535 ( BDP +FF ) , Administered Via pMDI , Moderate Severe Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Written inform consent Outpatients sex , age &gt; 12 year Moderate severe symptomatic asthma Forced expiratory volume first second ( FEV1 ) &gt; 40 % &lt; 80 % predict normal value Reversibility test `` Partly control '' asthma ( GINA revise 2006 ) Patients free longacting beta2agonists ( LABAs ) treatment Under inhaled corticosteroid ( ICS ) treatment A minimum inspiratory flow ≥ 40 L/min 10 . Nonsmokers ex smoker Asthma Control Questionnaire ACQ score ≥ 1.5 Pregnant nursing ( lactate ) woman Women childbearing potential , UNLESS menopausal acceptable method contraception Significant seasonal variation asthma asthma occur episodic exposure allergen chemical sensitizer History near fatal asthma Occurrence asthma exacerbation respiratory tract infection 6 week precede screen visit Diagnosis COPD History cystic fibrosis , bronchiectasis alpha1 antitrypsin deficiency Diagnosis restrictive lung disease Patients treat oral parenteral corticosteroid previous 2 month ( 3 month parenteral depot corticosteroid ) Intolerance contraindication treatment beta2agonists and/or inhaled corticosteroid Allergy component study treatment Any change dose , schedule , formulation product inhale corticosteroid 4 week prior screen visit Significant medical history and/or treatment cardiac , renal , neurological , hepatic , endocrine disease , laboratory abnormality ; Patients abnormal QTc</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>